Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Giant cell arteritis: suspicion and follow-up in the community

Internal medicine and immunology · Symptom or situation · updated 2026-10-30

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: About 10 cases per 100 000 inhabitants over 50 years per year in France; mean age around 70 years, 3 women for 1 man [1]

Suspected giant cell arteritis (after age 50)

Laboratory tests (the same day)

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

Do not order

Treated giant cell arteritis: laboratory monitoring

1 to 2 weeks after starting corticosteroids

At 1 month

Every month

Every 3 months (fasting)

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Sources (8)
  1. Groupe d'étude français des artérites des gros vaisseaux (GEFA), filière FAI²R. Protocole national de diagnostic et de soins (PNDS) : artérite à cellules géantes (Horton). Haute Autorité de santé, janvier 2024.
  2. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : acte 1577 (HbA1c) et sous-chapitre 7-03 auto-immunité (acte 1462, ANCA) ; absence d'acte actif pour la vitesse de sédimentation.
  3. Fragoulis GE, Nikiphorou E, Dey M, et al. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2023;82(6):742-753.
  4. Mackie SL, Dejaco C, Appenzeller S, et al. British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis. Rheumatology (Oxford). 2020;59(3):e1-e23.
  5. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : acte 4103 (test IGRA), conditions de prise en charge.
  6. Kermani TA, Schmidt J, Crowson CS, et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum. 2012;41(6):866-71.
  7. Raleigh MF, Stoddard J, Darrow HJ. Polymyalgia Rheumatica and Giant Cell Arteritis: Rapid Evidence Review. Am Fam Physician. 2022;106(4):420-426.
  8. Maz M, Chung SA, Abril A, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Care Res (Hoboken). 2021;73(8):1071-1087.